Rothmund-Thomson Syndrome  >>  Tracleer (bosentan)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
BUILD 3, NCT00391443 / 2006-001183-24: Bosentan Use in Interstitial Lung Disease

Completed
3
616
Japan, US, Canada, Europe, RoW
Bosentan, Ro 47-0203, ACT-050088, Placebo
Actelion
Idiopathic Pulmonary Fibrosis
02/10
07/10
BUILD OL, NCT00631475 / 2007-001741-18: Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Completed
3
128
Japan, US, Canada, Europe, RoW
Bosentan, Tracleer
Actelion
Idiopathic Pulmonary Fibrosis
04/10
05/10
BUILD 1, NCT00071461: Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Completed
2/3
158
US, Canada, Europe, RoW
bosentan, Tracleer, Placebo
Actelion
Idiopathic Pulmonary Fibrosis
09/05
05/10

Download Options